Project Grant R01AI192205
- Federal Project Grant Award Summary The University of Pennsylvania received a $822,015 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 6, 2025, with a completion date of July 31, 2026. The grant funds the development of novel statistical methodologies to address critical methodological challenges in infectious disease research, specifically causal identification theory...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Trustees of The University of Pennsylvania a Project Grant totaling $803,591 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 3, 2026 through January 31, 2031. This research initiative focuses on developing shiv-infected rhesus macaques as a preclinical model for human immunodeficiency virus type 1 (HIV-1) broadly neutralizing antibodies...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pennsylvania a $3.64 million Project Grant on July 8, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop immunoengineering strategies for durable control of human immunodeficiency virus (HIV) replication. The award supports a multi-project consortium through May 31, 2030, aimed at advancing chimeric antigen receptor (CAR) T cell therapy as...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $489,500 to The Children's Hospital of Philadelphia Research Institute on June 11, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This two-year project, which extends through May 31, 2027, focuses on developing novel sequencing methodologies and analytical pipelines to identify and characterize intact human immunodeficiency virus (HIV) reservoir cells...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pennsylvania a $891,410 Project Grant on August 14, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and test a personalized therapeutic HIV vaccine strategy. The research, scheduled for completion by July 31, 2030, focuses on designing individualized messenger RNA (mRNA)-lipid nanoparticle (LNP) delivered envelope immunogens to boost...
- Federal Project Grant Award Summary The University of Pennsylvania received a $486,057 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 6, 2025, with a completion date of May 31, 2030. The award supports the development of a multipronged messenger ribonucleic acid (mRNA) gene therapy approach to achieve an HIV cure, addressing the critical challenge of HIV-1 latency and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded UC San Diego a $812,427 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. The award supports development of an HIV Molecular Epidemiology Dashboard designed to integrate de-identified and aggregated HIV sequence data with publicly available national HIV prevention and treatment data from the AIDSVu platform....
- Federal Project Grant Award Summary The University of Pittsburgh received a $790,847 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 10, 2026, with completion targeted for January 31, 2031. This award supports investigative research into HIV-1 resistance pathways against lenacapavir (LEN), a potent capsid inhibitor approved for both treatment and prevention of HIV...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $145,299 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025 through July 31, 2029. This award supports the development of novel Bayesian causal structural discovery and reinforcement learning methods to advance precision medicine in HIV care, specifically addressing the challenge of designing...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Wistar Institute of Anatomy and Biology a $162,000 Project Grant on February 5, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research titled "Defining the Single-Cell Epigenetic Landscape of the HIV-1 Reservoir for Effective Latency Reversal." The research project, to be completed by January 31, 2028, will advance understanding...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Pennsylvania State University a Project Grant totaling $842,720 on April 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The five-year project, concluding March 31, 2031, will develop statistical models and methodologies to address critical information gaps in the global HIV response. The deliverables include longitudinal and spatial estimates of key populations in Sub-Saharan Africa countries with generalized HIV epidemics; HIV incidence inference for sub-national areas and populations at high risk; and open-source software implementing the proposed statistical methods to support evidence-based HIV policy and program design. The project will produce freely available research tools and collaborate with global and local organizations to disseminate findings and methodologies. By leveraging newly available HIV-related data and state-of-the-art analytical approaches, the research aims to identify geographic regions and populations where the HIV response is underperforming, thereby enabling more effective and efficient public health interventions aligned with global targets for reducing new infections.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $842.7k | 4/2/26 |